OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Physiology-Endocrinology and Metabolism is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
COVID-19 pandemic, coronaviruses, and diabetes mellitus	550
Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes	147
New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity	124
COVID-19 and vitamin D—Is there a link and an opportunity for intervention?	102
Bilirubin as a metabolic hormone: the physiological relevance of low levels	88
Melatonin ameliorates excessive PINK1/Parkin-mediated mitophagy by enhancing SIRT1 expression in granulosa cells of PCOS	82
DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K/Akt/mTOR signaling pathway	80
COVID-19-associated SIADH: a clue in the times of pandemic!	76
Mitochondrial-derived peptides in energy metabolism	65
Blueberry proanthocyanidins and anthocyanins improve metabolic health through a gut microbiota-dependent mechanism in diet-induced obese mice	59
Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity	57
COVID-19 endocrinopathy with hindsight from SARS	52
Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness severity	50
Sex-derived attributes contributing to SARS-CoV-2 mortality	50
An update on brown adipose tissue biology: a discussion of recent findings	47
Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection	46
Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?	45
Cholesterol: A new game player accelerating vasculopathy caused by SARS-CoV-2?	44
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8	44
The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism	44
Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling	41
Differential intestinal and oral microbiota features associated with gestational diabetes and maternal inflammation	40
A ketogenic diet combined with exercise alters mitochondrial function in human skeletal muscle while improving metabolic health	38
Dihydroceramides: their emerging physiological roles and functions in cancer and metabolic diseases	37
Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes	37

SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19	36
Type 2 diabetes: one disease, many pathways	34
Insulin Action in the Brain regulates both Central and Peripheral Functions	34
Mitochondrial dysfunction plays a key role in the development of neurodegenerative diseases in diabetes	34
Diabetic ferroptosis plays an important role in triggering on inflammation in diabetic wound	33
100^th anniversary of the discovery of insulin perspective: insulin and adipose tissue fatty acid metabolism	33
Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice	33
High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling	33